chapter 1 Historical Development of Dissolution Testing / chapter 2 Compendial Testing Equipment: Calibration, Qualification, and Sources of Error / chapter 3 Compendial Requirements of Dissolution Testing�European Pharmacopoeia, Japanese Pharmacopoeia, United States Pharmacopeia / chapter 4 The Role of Dissolution Testing in the Regulation of Pharmaceuticals: The FDA Perspective / chapter 5 Gastrointestinal Transit and Drug Absorption / chapter 6 Physiological Parameters Relevant to Dissolution Testing: Hydrodynamic Considerations / chapter 7 Development of Dissolution Tests on the Basis of Gastrointestinal Physiology / chapter 8 Orally Administered Drug Products: Dissolution Data Analysis with a View to In Vitro�In Vivo Correlation / chapter 9 Interpretation of In Vitro�In Vivo Time Profiles in Terms of Extent, Rate, and Shape / chapter 10 Study Design Considerations for IVIVC Studies / chapter 11 Dissolution Method Development with a View to Quality Control / chapter 12 Dissolution Method Development: An Industry Perspective / chapter 13 Design and Qualification of Automated Dissolution Systems. Dale VonBehren and Stephen Dobro -- chapter 14 Bioavailability of Ingredients in Dietary Supplements: A Practical Approach to the In Vitro Demonstration of the Availability of Ingredients in Dietary Supplements